Leadingpharm (Chongqing) was awarded the title of

In the second batch of 2023 evaluation of Chongqing Innovative Small & Medium-sized Enterprises organized by the Chongqing Municipal Commission of Economy and Information Technology, Leadingpharm (Chongqing) was successfully awarded the title of "Chongqing Innovative Small & Medium sized Enterprise" through strict review, publicity and other procedures.
 

As the first pharmaceutical research and development enterprise to settle in Yongchuan, Leadingpharm (Chongqing) has continuously strengthened its pharmaceutical research foundation and improved its technical level with the strong support of leaders at all levels of the Yongchuan District Committee and Government. It has carried out more than 30 research and development projects(including 11 improved new drug projects), applied for 10 patents, and nearly 20 high-end raw material and formulation projects are being vigorously promoted in the laboratory. Leadingpharm (Chongqing) has efficiently completed the construction of the quality system, and obtained ISO9001 quality management system certification and drug production license B certificate in 2023. The cooperation between industry, academia, and research is synchronous, and strategic cooperation has been reached with the School of Pharmacy of Chongqing University and Yongchuan Hospital affiliated with Chongqing Medical University. The Graduate Joint Training Base of the School of Pharmacy of Chongqing University, Practical Training Base of the School of Pharmacy of Chongqing University, and Entrepreneurship Base for College Students of the School of Pharmacy of Chongqing University have been successively listed.
 

Innovation is the driving force behind the sustained and rapid development of enterprises. The successful evaluation of Leadingpharm (Chongqing) as an innovative small & medium enterprise in Chongqing is a recognition of the company's professional level, innovation ability, and development potential. In the future, Leadingpharm will continuously increase investment in scientific research and innovation, break through the core technology of pharmaceutical research and development, comprehensively transform and upgrade, provide assistance to drive the high-quality development of enterprises and industries, and move towards higher echelons such as "specialization, refinement, uniqueness, and novelty"!